Title
Category
Credits
Event date
Cost
Infection Control: The New York Requirement
  • State Mandated Training
  • Pharmacology
  • 5.00 AMA PRA Category 1 Credit™
  • 5.00 ANCC
$35.00
Healthcare professionals have the responsibility to adhere to scientifically accepted principles and practices of infection control in all healthcare settings and to oversee and monitor those medical and ancillary personnel for whom the professional is responsible. This course provides the information necessary for healthcare professionals to monitor, control, and prevent infection in healthcare settings.
Pain Management Pearls: Opioids and Culture
  • Pharmacology
  • Pain Management: Opioid(s)
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 ANCC
$15.00
Pain affects all domains of life, and clinicians have few effective tools at their disposal to help these patients. Opioids remain the strongest group of analgesic drugs available. Millions of patients are safely and effectively maintained on relatively high-dose opioids for chronic, severe pain and require these medications to function. However, opioids, like many medications, have serious risks and should not be treated like a cure-all. This dichotomy has resulted in many patients for whom opioid analgesics are appropriate increasingly experiencing barriers to pain relief.
Developing a Safe Opioid Treatment Plan for Managing Chronic Pain
  • Pharmacology
  • Pain Management: Chronic
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
$15.00
Healthcare professionals should know best clinical practices in opioid prescribing, including the associated risks of opioids, approaches to the assessment of pain and function, and pain management modalities. Patients with moderate-to-severe chronic pain who have been assessed and treated, over a period of time, with non-opioid pharmacologic or nonpharmacologic pain therapy without adequate pain relief are considered to be candidates for a trial of opioid therapy.
Responsible Prescribing of Controlled Substances: The Louisiana Requirement
  • State Mandated Training
  • Prescribing: Controlled Substance(s)
  • Pharmacology
  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 ANCC
$21.00
Opioid analgesic medications can bring substantial relief to patients suffering from pain. However, the inappropriate use, abuse, and diversion of prescription drugs in America, particularly prescription opioids, has increased dramatically in recent years and has been identified as a national public health epidemic. A set of clinical tools, guidelines, and recommendations are now available for prescribers who treat pain patients with opioids.
Frontotemporal Dementia
  • Cognitive Impairment
  • Pharmacology
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 ANCC
$15.00
Frontotemporal dementia (FTD) is a group of degenerative brain disorders causing progressive deterioration in behavior, language, and/or movement. There are presently approximately 60,000 people with FTD in the United States. Onset generally occurs between 50 and 70 years of age, making FTD one of the most common presenile dementias. FTD affects the frontal and temporal lobes of the brain, which control emotions, judgment, personality, memory and language. The clinical diagnosis of FTD can be challenging, as some symptoms overlap with Alzheimer disease and other forms of dementia.
Responsible and Effective Opioid Prescribing
  • Prescribing: Opioid(s)
  • Pharmacology
  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 ANCC
$21.00
Opioid analgesic medications can bring substantial relief to patients suffering from pain. However, the inappropriate use, abuse, and diversion of prescription drugs in America, particularly prescription opioids, has increased dramatically in recent years and has been identified as a national public health epidemic. A set of clinical tools, guidelines, and recommendations are now available for prescribers who treat pain patients with opioids.
Opioid Use Disorder
  • Opioid Use Disorder (OUD)
  • Pharmacology
  • 10.00 AMA PRA Category 1 Credit™
  • 10.00 ANCC
  • 10.00 Association of Social Work Boards (ASWB)
$70.00
Morphine and heroin were first synthesized and used medicinally in the nineteenth century, and recreational and illicit use followed. Historically, heroin dependence has been difficult to treat successfully, with poor outcome being attributed to patient characteristics, environmental factors, and the powerful reinforcing effects of the drug. Agonist-replacement therapy was introduced more than 40 years ago and represented a breakthrough in the management of heroin addiction.